| Financial Year |
March 31 2023 |
| Monetary Funds |
148,344,651.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,462,201.00 |
| Accounts Receivable |
513,844,106.60 |
| Advances to Suppliers |
179,409,127.25 |
| Other Receivables |
27,635,696.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
284,924,787.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
88,566,578.55 |
| Total Current Assets |
1,248,437,148.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
168,329,969.82 |
| Fixed Assetes |
1,767,589,590.32 |
| Under-construction Projects |
796,919,185.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
350,047,138.62 |
| R&D expenses |
12,679,798.57 |
| Goodwill |
5,161,845.54 |
| Long-Term Deferred and Prepaid Expenses |
2,575,830.90 |
| Deferred Income Tax Assets |
76,961,751.59 |
| Other Non-Current Assets |
96,538,389.56 |
| Sub-Total of Non-Current Assets |
3,297,257,152.07 |
| Total Assets |
4,545,694,300.30 |
| Short-Term Loans |
394,519,008.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,280,000.00 |
| Accounts Payable |
252,565,013.75 |
| Accounts Received In Advance |
117,407.33 |
| Employee Compensation Payable |
92,246,091.11 |
| Taxes Payable |
5,554,294.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
225,680,677.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,223,523.89 |
| Other Current Liabilities |
14,562,712.23 |
| Sub-Total of Current Liabilities |
1,292,208,065.68 |
| Long-term Loans |
482,080,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,763,879.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
509,157,465.23 |
| Total Liabilities |
1,801,365,530.91 |
| Paid-In Capital(Or Share Stock) |
1,693,134,201.00 |
| Capital Surplus |
2,582,905,798.25 |
| Surplus Reserve |
258,348,625.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,823,250,207.87 |
| Minority Stockholder's Interest |
-14,893,136.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,759,221,905.47 |
| Owner's Equity（Stockholder's Equity） |
2,744,328,769.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,545,694,300.30 |
